Hematologic Malignancies
News
How Does Military Service Impact Cancer Risk? It’s Complicated
While it’s extremely difficult to link cancer rates to military service, researchers are starting to get some initial...
Conference Coverage
When to treat DLBCL with radiotherapy?
Choices depend on factors like evidence of disease, radiologists say.
Case Reports
Metastatic Urothelial Carcinoma Presenting as Mediastinal Lymphadenopathy Without Appreciable Bladder Mass in a Patient With Chronic Lymphocytic Leukemia
News
FDA approves motixafortide for stem cell mobilization in myeloma
Motixafortide has been approved by the FDA to help mobilize hematopoietic stem cells in autologous transplants for patients with multiple myeloma...
Original Research
Chimeric Antigen Receptor T-Cell Therapy in the Veterans Affairs Network: the Tennessee Valley Healthcare System Experience
Case Reports
Does Gemcitabine Have a Curative Role in Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia?
Case Reports
Asciminib Chronic Phase Chronic Myeloid Leukemia: A Real-World Single Institution Case Series
Original Research
Rasburicase Use and Glucose-6-Phosphate Dehydrogenase Testing
Original Research
Comparing Outcomes and Toxicities With Standard and Reduced Dose Melphalan in Autologous Stem Cell Transplant Patients With Multiple Myeloma
News
For CLL, BTKi combo bests chemoimmunotherapy
Phase 3 FLAIR trial yields more evidence that younger patients fared better with two-drug combo than with FCR, the once-standard therapy.